Constipation, a prevalent gastrointestinal disorder, often poses diagnostic and therapeutic challenges in clinical practice. A comprehensive approach is crucial for effective management.
Before initiating treatment for constipation, a thorough clinical evaluation is essential. This includes a detailed patient history, physical examination, and when necessary, specialized tests such as colonic transit studies, anorectal manometry, or defecography. The goal is to differentiate functional constipation from secondary causes and other defecatory disorders.
Management strategies should be individualized, starting with lifestyle modifications, including dietary changes and physical activity. Pharmacological treatment may be considered if these measures are ineffective. Bulk-forming, osmotic, and stimulant laxatives are commonly used. Newer agents such as lubiprostone, linaclotide, and plecanatide can be considered for patients with chronic idiopathic constipation.
In patients with dyssynergic defecation, biofeedback therapy is considered the first-line treatment. It is a non-invasive, safe, and effective therapy that improves symptoms by retraining the pelvic floor muscles.
Surgery should be considered as a last resort, only for patients with severe, refractory constipation, and after careful evaluation. Procedures such as subtotal colectomy and ileorectal anastomosis can provide relief in carefully selected patients.
Understanding the complexities of constipation diagnosis and treatment is key to successful patient management. A comprehensive, patient-centered approach that encompasses lifestyle modifications, pharmacological treatment, and when necessary, biofeedback therapy or surgery, can help untangle the knot of constipation in clinical practice.
1.
Both men and women who receive the HPV vaccine have a lower risk of developing multiple cancer types.
2.
Potentially Novel Approach for Treating Advanced Colorectal Cancer with KRAS Mutations.
3.
CAR-T cell therapy for cancer causes 'brain fog,' study shows
4.
In Acute Myeloid Leukemia Diagnosed Recently, FLT3 Inhibitor Is Very Effective.
5.
Cancer research in the US is world class. With the government pulling out, its future is uncertain
1.
Environmental Carcinogen Exposure Risk Modeling: Current Evidence and Clinical Implications
2.
Screening for Cancer-Related Neuromuscular Weakness: Clinical Approaches and Evidence-Based Strategies
3.
A Closer Look at White Blood Cells in Urine: Uncovering the Causes and Treatments
4.
The Silent Killer: Uncovering the Causes and Treatments of Hemorrhagic Gastritis
5.
Exploring The Causes and Consequences of Low Transferrin Saturation
1.
International Conference on Oncology, Cardiology and Critical Care Policy
2.
International Conference on Innovations in Critical Care for Oncology and Cardiology
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Cancer Nursing and Hematology Support
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation